ArticleBMC cancer2018

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.

Guang-Hua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.